Clinical Trial Update: Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes [NA]

View source ↗

Summary

A completed clinical trial comparing the pharmacodynamic effects of prasugrel versus ticagrelor in patients with diabetes mellitus and coronary artery disease; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• BRILINTA (ticagrelor)
• EFFIENT (prasugrel hydrochloride)

Snippet

Sponsor: University of Florida | Conditions: Diabetes Mellitus, Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2016-10-17